Cargando…

Safety and efficacy of sunitinib in patients from Latin America: subanalysis of an expanded access trial in metastatic renal cell carcinoma

BACKGROUND: Sunitinib is an approved treatment for metastatic renal cell carcinoma (mRCC). The safety profile and efficacy of sunitinib were confirmed in a global expanded access trial (ClinicalTrials.gov identifier: NCT00130897). This report presents a subanalysis of the final trial data from patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barrios, Carlos H, Herchenhorn, Daniel, Chacón, Matías, Cabrera-Galeana, Paula, Sajben, Peter, Zhang, Ke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Clinical Trial Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045222/ https://www.ncbi.nlm.nih.gov/pubmed/27713637 http://dx.doi.org/10.2147/OTT.S109445

Ejemplares similares

Long-term benefit of sunitinib in patients with metastatic renal cell carcinoma in Latin America: retrospective analysis of patient clinical characteristics
por: Smaletz, Oren, et al.
Publicado: (2016)

Expanding access to financial services in Latin America
Publicado: (1995)

Final results from the large sunitinib global expanded-access trial in metastatic renal cell carcinoma
por: Gore, M E, et al.
Publicado: (2015)

Dual Antiplatelet Therapy Using Cilostazol With Aspirin or Clopidogrel: Subanalysis of the CSPS.com Trial
por: Hoshino, Haruhiko, et al.
Publicado: (2021)

Phase III randomized trial of sunitinib versus capecitabine in patients with previously treated HER2-negative advanced breast cancer
por: Barrios, Carlos H., et al.
Publicado: (2010)

Effect of febuxostat on the level of malondialdehyde‐modified low‐density lipoprotein, an oxidative stress marker: A subanalysis of the PRIZE study
por: Teragawa, Hiroki, et al.
Publicado: (2023)

Access to high-cost drugs for advanced breast cancer in Latin America, particularly trastuzumab
por: Barrios, Carlos Henrique, et al.
Publicado: (2019)

3162 Colonization of Pregnant Women with Group B streptococcus in Latin America and Infant Outcomes
por: HogenEsch, Elena, et al.
Publicado: (2019)

Access and barriers to MS care in Latin America
por: Rivera, Víctor M, et al.
Publicado: (2017)

Physical Activity Interventions in Latin America: Expanding and Classifying the Evidence
por: Hoehner, Christine M., et al.
Publicado: (2013)

Expanding Pertussis Epidemiology in 6 Latin America Countries through the Latin American Pertussis Project
por: Pinell-McNamara, Veronica A., et al.
Publicado: (2017)

Efficacy and safety of sunitinib in elderly patients with metastatic renal cell carcinoma
por: Hutson, T E, et al.
Publicado: (2014)

SAMETA: A Phase III study of savolitinib + durvalumab vs sunitinib and durvalumab monotherapy in patients with MET-driven, unresectable, locally advanced/metastatic papillary renal cell carcinoma
por: Chouieri, Toni
Publicado: (2023)

Sunitinib treatment in patients with advanced renal cell cancer: the Brazilian National Cancer Institute (INCA) experience
por: Coelho, Rafael Corrêa, et al.
Publicado: (2016)

Climate change beliefs and their correlates in Latin America
por: Spektor, Matias, et al.
Publicado: (2023)

Prognostic factors for survival in 1059 patients treated with sunitinib for metastatic renal cell carcinoma
por: Motzer, R J, et al.
Publicado: (2013)

Menstrual hygiene access and practices in Latin America: scoping review
por: de Oliveira, Viviane Caroline, et al.
Publicado: (2023)

Latin America /
por: Goodwin, Paul B., 1942-
Publicado: (2000)

Immunohistochemistry study of tumor vascular normalization and anti-angiogenic effects of sunitinib versus bevacizumab prior to dose-dense doxorubicin/cyclophosphamide chemotherapy in HER2-negative breast cancer
por: Yadav, Kritika, et al.
Publicado: (2021)

Randomized Phase II Trial of Sunitinib or Cediranib in Alveolar Soft Part Sarcoma
por: Nguyen, James, et al.
Publicado: (2023)

Blinatumomab in pediatric relapsed/refractory B-cell acute lymphoblastic leukemia: RIALTO expanded access study final analysis
por: Locatelli, Franco, et al.
Publicado: (2022)

Access to medicines in Latin America and the Caribbean (LAC): a scoping study
por: Emmerick, Isabel Cristina Martins, et al.
Publicado: (2013)

The Urgent Need for Management of Biological Samples and Data Accessibility in Latin America
por: Vargas, Rodrigo José, et al.
Publicado: (2021)

Latin America and access to Assisted Reproductive Techniques: A Brazilian perspective
por: de Souza, Maria do Carmo B.
Publicado: (2014)

Hypofractionation as a solution to radiotherapy access in latin america: expert perspective
por: Santos, Marcos, et al.
Publicado: (2022)

HIV and COVID-19 in Latin America and the Caribbean
por: Garcia, Patricia J., et al.
Publicado: (2022)

Expanded Access Protocol of Umbilical Cord Blood Infusion for Children with Neurological Conditions: An Update
por: McLaughlin, Colleen, et al.
Publicado: (2021)

Induction of trismus by sunitinib and pazopanib in metastatic renal cell carcinoma
por: Iyer, Ridhima, et al.
Publicado: (2017)

Complete remission of metastatic renal cell carcinoma to the bone with sunitinib
por: Yoshimura, Akihiro, et al.
Publicado: (2020)

Metastatic atypical renal tumour with metanephric characteristics treated with Sunitinib
por: Mohammad, H., et al.
Publicado: (2021)

Latin America : the politics of immobility
por: Adie, Robert F., 1936-
Publicado: (1974)

Latin America : diplomacy and reality
por: Berle, Adolf A., Jr., 1895-1971
Publicado: (1962)

Latin America : an interpretive history
por: Dozer, Donald Marquand
Publicado: (1962)

Invisible Latin América
por: Shapiro, Samuel, 1920-
Publicado: (1963)

The Independence of Latin America /
Publicado: (1987)

Musics of Latin America
Publicado: (2012)

Modern Latin America
por: Stark, Harry
Publicado: (1957)

Inside Latin America
por: Gunther, John, 1901-1970
Publicado: (1941)

Latin America and the war
por: Martin, Percy Alvin
Publicado: (1925)

Intervention in Latin America
Publicado: (1970)

Cannot write session to /tmp/vufind_sessions/sess_ldfb7d2oaj7641m2p3j0r0vjkv